EORTC-62092-22092-STBSG-ROG

Back to Clinical Trials Database

A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS

Study documentation Publications

Trial Status	Closed to Patient Entry
Dates	Date of activation: 16-Jan-2012 Date Step1 close: 11-Apr-2017
Data management at EORTC	Yes
Design	Phase 3 Randomized open label
Targeted Sample size	EORTC Groups: 256 - All Groups: 256
Treatment	Radiotherapy, Surgery
Study Staff	Sylvie Bonvalot (Study Coordinator) , Institut Curie- Hopital de Paris, Paris Rick Haas (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam Stephanie Kromar (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Saskia Litiere (Statistician) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) , EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Lucia Senna (Clinical Operations Assistant) , EORTC Headquarters, Brussels Ionela Stanciu (Junior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer	Soft Tissue and Bone Sarcoma
Participating groups	EORTC Radiation Oncology Group EORTC Soft Tissue and Bone Sarcoma Group
Recruiting centers	Centre Antoine Lacassagne (Nice, France) Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame (Montreal, Canada) Centre Leon Berard (Lyon, France) Centro Di Riferimento Oncologico (Aviano, Italy) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Gustave Roussy (Villejuif, France) Herlev Hospital - University Copenhagen (Herlev, Denmark) Hospital Universitario San Carlos (Madrid, Spain) IRCCS - Istituto Nazionale dei Tumori (Milano, Italy) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut Bergonie (Bordeaux, France) Institut Claudius Regaud (Toulouse, France) Institut Curie- Hopital de Paris (Paris, France) Institut Jules Bordet-Hopital Universitaire ULB (Brussels, Belgium) Istituto Clinico Humanitas (Rozzano, Milano, Italy) Karolinska University Hospital, location Solna (Stockholm, Sweden) Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom) Leiden University Medical Centre (Leiden, Netherlands) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Maria Sklodowska Curie - Curie’s National Institute of Oncology – National Research Institute (Warsaw, Poland) Mount Sinai Hospital (Toronto, Ontario, Canada) Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Oslo University Hospital - Radiumhospitalet (Oslo, Norway) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom) Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) The Christie NHS Foundation Trust (Manchester, United Kingdom) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) UHB-Queen Elisabeth Medical Centre (Birmingham, United Kingdom) UniversitaetsMedizin Mannheim (Mannheim, Germany) Universitaetsklinikum Koeln (Koeln, Germany) University College Hospital (London, United Kingdom) University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom) University Medical Center Groningen (Groningen, Netherlands) Vall d'Hebron Institut Oncologia (Barcelona, Spain) Western General Hospital (Edinburgh, United Kingdom)
Protocol summary	http://clinicaltrials.gov/ct/show/NCT01344018
NCT number	NCT01344018
Financial Support	Academic Fund EORTC Group External Grant